Volastra Therapeutics today announced the dosing of the first patient in a Phase I/II clinical trial evaluating VLS-1488.

--atai Life Sciences, a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, announced the completion of the Phase 1 study of VLS-01 in healthy ...

“We are pleased to receive FDA Fast Track and Orphan Drug designation for VLS-101 in mantle cell lymphoma, which is a significant milestone for VelosBio as we continue to advance our pipeline of ...

The Phase 1b trial of VLS-01 investigates the pharmacokinetics, pharmacodynamics, safety and tolerability of atai’s proprietary, optimized oral transmucosal formulation of DMT VLS-01 is being ...

- Elumina is a Phase 2, multicenter, double-blind, randomized, placebo-controlled, clinical trial to assess the efficacy, safety and tolerability of VLS-01 (buccal film DMT) in people suffering ...

In a bid to improve the Mogami class's anti-submarine warfare (ASW) capabilities, Japan has begun installing the vertical launching system (VLS) on selected hulls of the ...

The UK Royal Navy (RN) has revealed plans to install the Lockheed Martin Mk 41 vertical launching system (VLS) into its five new Type 31 Inspiration-class general-purpose frigates.